TABLE 1 Europe Biosimilars Market, 2018 - 2021, USD Million
TABLE 2 Europe Biosimilars Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Biosimilars Market
TABLE 4 Product Launches And Product Expansions– Biosimilars Market
TABLE 5 Acquisition and Mergers– Biosimilars Market
TABLE 6 Approvals and Trials – Biosimilars Market
TABLE 7 Europe Biosimilars Market by Application, 2018 - 2021, USD Million
TABLE 8 Europe Biosimilars Market by Application, 2022 - 2028, USD Million
TABLE 9 Europe Oncology Diseases Market by Country, 2018 - 2021, USD Million
TABLE 10 Europe Oncology Diseases Market by Country, 2022 - 2028, USD Million
TABLE 11 Europe Blood Disorders Market by Country, 2018 - 2021, USD Million
TABLE 12 Europe Blood Disorders Market by Country, 2022 - 2028, USD Million
TABLE 13 Europe Chronic & Autoimmune Diseases Market by Country, 2018 - 2021, USD Million
TABLE 14 Europe Chronic & Autoimmune Diseases Market by Country, 2022 - 2028, USD Million
TABLE 15 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 16 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 17 Europe Biosimilars Market by Type, 2018 - 2021, USD Million
TABLE 18 Europe Biosimilars Market by Type, 2022 - 2028, USD Million
TABLE 19 Europe Monoclonal Antibodies Market by Country, 2018 - 2021, USD Million
TABLE 20 Europe Monoclonal Antibodies Market by Country, 2022 - 2028, USD Million
TABLE 21 Europe Granulocyte-Colony Stimulating Factor Market by Country, 2018 - 2021, USD Million
TABLE 22 Europe Granulocyte-Colony Stimulating Factor Market by Country, 2022 - 2028, USD Million
TABLE 23 Europe Erythropoietin Market by Country, 2018 - 2021, USD Million
TABLE 24 Europe Erythropoietin Market by Country, 2022 - 2028, USD Million
TABLE 25 Europe Human Growth Hormone Market by Country, 2018 - 2021, USD Million
TABLE 26 Europe Human Growth Hormone Market by Country, 2022 - 2028, USD Million
TABLE 27 Europe Insulin Market by Country, 2018 - 2021, USD Million
TABLE 28 Europe Insulin Market by Country, 2022 - 2028, USD Million
TABLE 29 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 30 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 31 Europe Biosimilars Market by Country, 2018 - 2021, USD Million
TABLE 32 Europe Biosimilars Market by Country, 2022 - 2028, USD Million
TABLE 33 Germany Biosimilars Market, 2018 - 2021, USD Million
TABLE 34 Germany Biosimilars Market, 2022 - 2028, USD Million
TABLE 35 Germany Biosimilars Market by Application, 2018 - 2021, USD Million
TABLE 36 Germany Biosimilars Market by Application, 2022 - 2028, USD Million
TABLE 37 Germany Biosimilars Market by Type, 2018 - 2021, USD Million
TABLE 38 Germany Biosimilars Market by Type, 2022 - 2028, USD Million
TABLE 39 UK Biosimilars Market, 2018 - 2021, USD Million
TABLE 40 UK Biosimilars Market, 2022 - 2028, USD Million
TABLE 41 UK Biosimilars Market by Application, 2018 - 2021, USD Million
TABLE 42 UK Biosimilars Market by Application, 2022 - 2028, USD Million
TABLE 43 UK Biosimilars Market by Type, 2018 - 2021, USD Million
TABLE 44 UK Biosimilars Market by Type, 2022 - 2028, USD Million
TABLE 45 France Biosimilars Market, 2018 - 2021, USD Million
TABLE 46 France Biosimilars Market, 2022 - 2028, USD Million
TABLE 47 France Biosimilars Market by Application, 2018 - 2021, USD Million
TABLE 48 France Biosimilars Market by Application, 2022 - 2028, USD Million
TABLE 49 France Biosimilars Market by Type, 2018 - 2021, USD Million
TABLE 50 France Biosimilars Market by Type, 2022 - 2028, USD Million
TABLE 51 Russia Biosimilars Market, 2018 - 2021, USD Million
TABLE 52 Russia Biosimilars Market, 2022 - 2028, USD Million
TABLE 53 Russia Biosimilars Market by Application, 2018 - 2021, USD Million
TABLE 54 Russia Biosimilars Market by Application, 2022 - 2028, USD Million
TABLE 55 Russia Biosimilars Market by Type, 2018 - 2021, USD Million
TABLE 56 Russia Biosimilars Market by Type, 2022 - 2028, USD Million
TABLE 57 Spain Biosimilars Market, 2018 - 2021, USD Million
TABLE 58 Spain Biosimilars Market, 2022 - 2028, USD Million
TABLE 59 Spain Biosimilars Market by Application, 2018 - 2021, USD Million
TABLE 60 Spain Biosimilars Market by Application, 2022 - 2028, USD Million
TABLE 61 Spain Biosimilars Market by Type, 2018 - 2021, USD Million
TABLE 62 Spain Biosimilars Market by Type, 2022 - 2028, USD Million
TABLE 63 Italy Biosimilars Market, 2018 - 2021, USD Million
TABLE 64 Italy Biosimilars Market, 2022 - 2028, USD Million
TABLE 65 Italy Biosimilars Market by Application, 2018 - 2021, USD Million
TABLE 66 Italy Biosimilars Market by Application, 2022 - 2028, USD Million
TABLE 67 Italy Biosimilars Market by Type, 2018 - 2021, USD Million
TABLE 68 Italy Biosimilars Market by Type, 2022 - 2028, USD Million
TABLE 69 Rest of Europe Biosimilars Market, 2018 - 2021, USD Million
TABLE 70 Rest of Europe Biosimilars Market, 2022 - 2028, USD Million
TABLE 71 Rest of Europe Biosimilars Market by Application, 2018 - 2021, USD Million
TABLE 72 Rest of Europe Biosimilars Market by Application, 2022 - 2028, USD Million
TABLE 73 Rest of Europe Biosimilars Market by Type, 2018 - 2021, USD Million
TABLE 74 Rest of Europe Biosimilars Market by Type, 2022 - 2028, USD Million
TABLE 75 key information – Fresenius SE & Co. KGaA
TABLE 76 key information – Dr. Reddy’s Laboratories Ltd.
TABLE 77 Key Information – Pfizer, Inc.
TABLE 78 Key Information – Amgen, Inc.
TABLE 79 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 80 Key Information – Eli Lilly And Company
TABLE 81 KEY INFORMATION - MERCK & CO., INC.
TABLE 82 Key Information – Novartis AG
TABLE 83 Key Information – Biocon Limited
TABLE 84 Key Information – Intas Pharmaceutical Ltd.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Partnerships, Collaborations & Agreements : 2018, Jan – 2022, Aug) Leading Players
FIG 5 Recent strategies and developments: Fresenius SE & Co. KGaA
FIG 6 Recent strategies and developments: Dr. Reddy’s Laboratories Ltd.
FIG 7 Recent strategies and developments: Pfizer, Inc.
FIG 8 Recent strategies and developments: Amgen, Inc.
FIG 9 Recent strategies and developments: Teva Pharmaceuticals Industries Ltd.
FIG 10 Recent strategies and developments: Novartis AG
FIG 11 Recent strategies and developments: Biocon Limited
FIG 12 Recent strategies and developments: Intas Pharmaceutical Ltd.
Unique Offerings 